227 research outputs found
Recommended from our members
L AREA WASTEWATER STORAGE DRUM EVALUATION
This report documents the determination of the cause of pressurization that led to bulging deformation of a 55 gallon wastewater drum stored in L-Area. Drum samples were sent to SRNL for evaluation. The interior surface of these samples revealed blistering and holes in the epoxy phenolic drum liner and corrosion of the carbon steel drum. It is suspected that osmotic pressure drove permeation of the water through the epoxy phenolic coating which was weakened from exposure to low pH water. The coating failed at locations throughout the drum interior. Subsequent corrosion of the carbon steel released hydrogen which pressurized the drum causing deformation of the drum lid. Additional samples from other wastewater drums on the same pallet were also evaluated and limited corrosion was visible on the interior surfaces. It is suspected that, with time, the corrosion would have advanced to cause pressurization of these sealed drums
A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing
As genome-scale sequencing is increasingly applied in clinical scenarios, a wide variety of genomic findings will be discovered as secondary or incidental findings, and there is debate about how they should be handled. The clinical actionability of such findings varies, necessitating standardized frameworks for a priori decision making about their analysis
Beyond crystal balls: crosscutting solutions in global health to prepare for an unpredictable future
Recommended from our members
Fiscal Year 2006
This report documents the results of the L-Basin Corrosion Surveillance Program for the fiscal years 2005 and 2006. The water quality and basin conditions for the coupon immersion period are compared to the corrosion evaluation results from detailed metallurgical analysis of the coupons. Test coupons were removed from the basin on two occasions, March 29, 2005 and May 23, 2006, examined and photographed. Selected coupons were metallurgically characterized to evaluate the extent of general corrosion and pitting. Crystallographic and energy dispersive spectroscopy analysis were performed on a typical specimen, as-removed from the basin, to characterize the surface debris. Marked changes were noted in both the 2005 and 2006 specimens compared to previous years corrosion results. A new pitting incidence has occurred on the faces of the aluminum coupons compared to localized pitting at crevice regions only on specimens withdrawn in 2003 and 2004. The pitting incidence is attributed to sand filter fines that entered the basin on July 27, 2004 from an inadvertent backflush of the new sand filter. Pitting rate results show a trend of slowing down over time which is consistent with aluminum pit kinetics. Average pit growth rates were equal to or lower in all 2006 aluminum coupons than those removed in 2005. A trend line shows that pitting corrosion rates on Al1100, 6061, and 6063 coupons are slowing down since pit depth measurements were initiated in 2003. No impact to stored spent fuel is expected from the debris. The storage configuration of the majority of L-Basin spent fuel, in bundles, should provide a measure of isolation from debris settling in the basin
Recommended from our members
Diagnostic Performance of CT-Guided Bone Biopsies in Patients with Suspected Osteomyelitis of the Appendicular and Axial Skeleton with a Focus on Clinical and Technical Factors Associated with Positive Microbiology Culture Results
PurposeTo assess diagnostic performance of CT-guided percutaneous needle bone biopsy (CTNBB) in patients with suspected osteomyelitis and analyze whether certain clinical or technical factors were associated with positive microbiology results.Materials and methodsAll CTNBBs performed in a single center for suspected osteomyelitis of the appendicular and axial skeleton during 2003-2018 were retrospectively reviewed. Specific inclusion criteria were clinical and radiologic suspicion of osteomyelitis. Standard of reference was defined using outcome of surgical histopathology and microbiology culture and clinical and imaging follow-up. Technical and clinical data (needle size, comorbidities, clinical factors, laboratory values, blood cultures) were collected. Logistic regression was performed to assess associations between technical and clinical data and microbiology biopsy outcome.ResultsA total of 142 CTNBBs were included (46.5% female patients; age ± SD 46.10 y ± 22.8), 72 (50.7%) from the appendicular skeleton and 70 (49.3%) from the axial skeleton. CTNBB showed a sensitivity of 42.5% (95% confidence interval [CI], 32.0%-53.6%) in isolating the causative pathogen. A higher rate of positive microbiology results was found in patients with intravenous drug use (odds ratio [OR] = 5.15; 95% CI, 1.2-21.0; P = .022) and elevated white blood cell count ≥ 10 × 109/L (OR = 3.9; 95% CI, 1.62-9.53; P = .002). Fever (≥ 38°C) was another clinical factor associated with positive microbiology results (OR = 3.6; 95% CI, 1.3-9.6; P = .011).ConclusionsCTNBB had a low sensitivity of 42.5% for isolating the causative pathogen. Rate of positive microbiology samples was significantly higher in patients with IV drug use, elevated white blood cell count, and fever
Avoiding Cribari gridlock 2: The standardized triage assessment tool outperforms the Cribari matrix method in 38 adult and pediatric trauma centers
From the “L Chamber” to the Wood-Pile: Negotiating Space in Harriet E. Wilson’s Our Nig
Rethinking the definition of major trauma: The need for trauma intervention outperforms Injury Severity Score and Revised Trauma Score in 38 adult and pediatric trauma centers
BACKGROUND Patients\u27 trauma burdens are a combination of anatomic damage, physiologic derangement, and the resultant depletion of reserve. Typically, Injury Severity Score (ISS) \u3e15 defines major anatomic injury and Revised Trauma Score (RTS) \u3c7.84 defines major physiologic derangement, but there is no standard definition for reserve. The Need For Trauma Intervention (NFTI) identifies severely depleted reserves (NFTI+) with emergent interventions and/or early mortality. We hypothesized NFTI would have stronger associations with outcomes and better model fit than ISS and RTS. METHODS Thirty-eight adult and pediatric U.S. trauma centers submitted data for 88,488 encounters. Mixed models tested ISS greater than 15, RTS less than 7.84, and NFTI\u27s associations with complications, survivors\u27 discharge to continuing care, and survivors\u27 length of stay (LOS). RESULTS The NFTI had stronger associations with complications and LOS than ISS and RTS (odds ratios [99.5% confidence interval]: NFTI = 9.44 [8.46-10.53]; ISS = 5.94 [5.36-6.60], RTS = 4.79 [4.29-5.34]; LOS incidence rate ratios (99.5% confidence interval): NFTI = 3.15 [3.08-3.22], ISS = 2.87 [2.80-2.94], RTS = 2.37 [2.30-2.45]). NFTI was more strongly associated with continuing care discharge but not significantly more than ISS (relative risk [99.5% confidence interval]: NFTI = 2.59 [2.52-2.66], ISS = 2.51 [2.44-2.59], RTS = 2.37 [2.28-2.46]). Cross-validation revealed that in all cases NFTI\u27s model provided a much better fit than ISS greater than 15 or RTS less than 7.84. CONCLUSION In this multicenter study, NFTI had better model fit and stronger associations with the outcomes than ISS and RTS. By determining depletion of reserve via resource consumption, NFTI+ may be a better definition of major trauma than the standard definitions of ISS greater than 15 and RTS less than 7.84. Using NFTI may improve retrospective triage monitoring and statistical risk adjustments. LEVEL OF EVIDENCE Prognostic, level IV
Pediatric Low-Grade Gliomas: Next Biologically Driven Steps.
Despite the fact that they are not typically life-threatening, low-grade gliomas (LGGs) remain a significant clinical challenge in pediatric neuro-oncology due to comorbidities associated with these tumors and/or their treatments, and their propensity to multiply recurs. LGGs, in total the most common brain tumors arising in childhood, can often become a chronic problem requiring decades of management. The Second International Consensus Conference on Pediatric Low-Grade Gliomas held in Padua, Italy in 2016 was convened in an attempt to advance the pace of translating biological discoveries on LGGs into meaningful clinical benefit. Topics discussed included: the implications of our growing biological understanding of the genomics underlying these tumors; the assessment of the model systems available; the implications of the molecular and histopathologic differences between adult and pediatric diffuse gliomas; and steps needed to expedite targeted therapy into late-stage clinical trials for newly diagnosed cases. Methods for the diagnostic assessment of alterations in the Ras/mitogen-activated protein kinase pathway, typical for these tumors, were also considered. While the overall tone was positive, with a consensus that progress is being and will continue to be made, the scale of the challenge presented by this complex group of tumors was also acknowledged. The conclusions and recommendations of the meeting panel are provided here as an outline of current thinking and a basis for further discussion
Pediatric low-grade gliomas: Implications of the biologic era
For the past decade, it has been recognized that pediatric low-grade gliomas (LGGs) and glial-neuronal tumors carry distinct molecular alterations with resultant aberrant intracellular signaling in the Ras-mitogen-activated protein kinase pathway. The conclusions and recommendations of a consensus conference of how best to integrate the growing body of molecular genetic information into tumor classifcations and, more importantly, for future treatment of pediatric LGGs are summarized here. There is uniform agreement that molecular characterization must be incorporated into classifcation and is increasingly critical for appropriate management. Moleculartargeted therapies should be integrated expeditiously, but also carefully into the management of these tumors and success measured not only by radiographic responses or stability, but also by functional outcomes. These trials need to be carried out with the caveat that the long-term impact of molecularly targeted therapy on the developing nervous system, especially with long duration treatment, is essentially unknown
- …